138 related articles for article (PubMed ID: 26137269)
1. Insulin-like growth factor 1 receptor expression in breast cancer tissue and mammographic density.
Sun WY; Yun HY; Song YJ; Kim H; Lee OJ; Nam SJ; Koo JS
Mol Clin Oncol; 2015 May; 3(3):572-580. PubMed ID: 26137269
[TBL] [Abstract][Full Text] [Related]
2. The impact of IGF-1R expression on the outcomes of patients with breast cancer: a meta-analysis.
Yan S; Jiao X; Li K; Li W; Zou H
Onco Targets Ther; 2015; 8():279-87. PubMed ID: 25674003
[TBL] [Abstract][Full Text] [Related]
3. Addition of zoledronic acid to neoadjuvant chemotherapy is not beneficial in patients with HER2-negative stage II/III breast cancer: 5-year survival analysis of the NEOZOTAC trial (BOOG 2010-01).
de Groot S; Pijl H; Charehbili A; van de Ven S; Smit VTHBM; Meershoek-Klein Kranenbarg E; Heijns JB; van Warmerdam LJC; Kessels LW; Dercksen MW; Pepels MJAE; van Laarhoven HWM; Vriens BEPJ; Putter H; Fiocco M; Liefers GJ; van der Hoeven JJM; Nortier JWR; Kroep JR;
Breast Cancer Res; 2019 Aug; 21(1):97. PubMed ID: 31455425
[TBL] [Abstract][Full Text] [Related]
4. Insulin-like growth factor-I (IGF-1), IGF-binding protein-3 (IGFBP-3) and mammographic features.
Izzo L; Meggiorini ML; Nofroni I; Pala A; De Felice C; Meloni P; Simari T; Izzo S; Pugliese F; Impara L; Merlini G; Di Cello P; Cipolla V; Forcione AR; Paliotta A; Domenici L; Bolognese A
G Chir; 2012 May; 33(5):153-62. PubMed ID: 22709450
[TBL] [Abstract][Full Text] [Related]
5. Expression of insulin-like growth factor 1 receptor in primary breast cancer: immunohistochemical analysis.
Shimizu C; Hasegawa T; Tani Y; Takahashi F; Takeuchi M; Watanabe T; Ando M; Katsumata N; Fujiwara Y
Hum Pathol; 2004 Dec; 35(12):1537-42. PubMed ID: 15619214
[TBL] [Abstract][Full Text] [Related]
6. The prognostic significance of the insulin-like growth factor-1 ligand and receptor expression in breast cancer tissue.
Chong KY; Subramanian A; Mokbel K; Sharma AK
J Surg Oncol; 2011 Sep; 104(3):228-35. PubMed ID: 21480260
[TBL] [Abstract][Full Text] [Related]
7. Expression and clinical significance of epidermal growth factor receptor and insulin-like growth factor receptor 1 in patients with ampullary adenocarcinoma.
Xia M; Overman MJ; Rashid A; Chatterjee D; Wang H; Katz MH; Fleming JB; Lee JE; Varadhachary GR; Wolff RA; Wang H
Hum Pathol; 2015 Sep; 46(9):1315-22. PubMed ID: 26165226
[TBL] [Abstract][Full Text] [Related]
8. Insulin-like growth factor-1 receptor (IGF-1R) expression does not predict for resistance to trastuzumab-based treatment in patients with Her-2/neu overexpressing metastatic breast cancer.
Köstler WJ; Hudelist G; Rabitsch W; Czerwenka K; Müller R; Singer CF; Zielinski CC
J Cancer Res Clin Oncol; 2006 Jan; 132(1):9-18. PubMed ID: 16184380
[TBL] [Abstract][Full Text] [Related]
9. Impact of phosphorylated insulin-like growth factor-1 receptor on the outcome of breast cancer patients and the prognostic value of its alteration during neoadjuvant chemotherapy.
Li L; Liu S; Liu L; Ma Z; Feng M; Ye C; Zhou W; Wang Y; Liu L; Wang F; Yu L; Zhou F; Xiang Y; Huang S; Fu Q; Zhang Q; Gao D; Yu Z
Exp Ther Med; 2018 Oct; 16(4):2949-2959. PubMed ID: 30233667
[TBL] [Abstract][Full Text] [Related]
10. Insulin-like growth factor-I, IGF-binding protein-3, and mammographic breast density.
Diorio C; Pollak M; Byrne C; Mâsse B; Hébert-Croteau N; Yaffe M; Coté G; Bérubé S; Morin C; Brisson J
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1065-73. PubMed ID: 15894654
[TBL] [Abstract][Full Text] [Related]
11. Positive expression of insulin-like growth factor-1 receptor is associated with a positive hormone receptor status and a favorable prognosis in breast cancer.
Shin SJ; Gong G; Lee HJ; Kang J; Bae YK; Lee A; Cho EY; Lee JS; Suh KS; Lee DW; Jung WH
J Breast Cancer; 2014 Jun; 17(2):113-20. PubMed ID: 25013431
[TBL] [Abstract][Full Text] [Related]
12. Circulating insulin-like growth factor-I, insulin-like growth factor binding protein-3 and terminal duct lobular unit involution of the breast: a cross-sectional study of women with benign breast disease.
Horne HN; Sherman ME; Pfeiffer RM; Figueroa JD; Khodr ZG; Falk RT; Pollak M; Patel DA; Palakal MM; Linville L; Papathomas D; Geller B; Vacek PM; Weaver DL; Chicoine R; Shepherd J; Mahmoudzadeh AP; Wang J; Fan B; Malkov S; Herschorn S; Hewitt SM; Brinton LA; Gierach GL
Breast Cancer Res; 2016 Feb; 18(1):24. PubMed ID: 26893016
[TBL] [Abstract][Full Text] [Related]
13. A polymorphic locus in the promoter region of the IGFBP3 gene is related to mammographic breast density.
Lai JH; Vesprini D; Zhang W; Yaffe MJ; Pollak M; Narod SA
Cancer Epidemiol Biomarkers Prev; 2004 Apr; 13(4):573-82. PubMed ID: 15066922
[TBL] [Abstract][Full Text] [Related]
14. The relationship between the insulin-like growth factor-1 system and the oestrogen metabolising enzymes in breast cancer tissue and its adjacent non-cancerous tissue.
Chong YM; Colston K; Jiang WG; Sharma AK; Mokbel K
Breast Cancer Res Treat; 2006 Oct; 99(3):275-88. PubMed ID: 16752221
[TBL] [Abstract][Full Text] [Related]
15. Insulin-like growth factor and mammographic density in postmenopausal Norwegian women.
Bremnes Y; Ursin G; Bjurstam N; Rinaldi S; Kaaks R; Gram IT
Cancer Epidemiol Biomarkers Prev; 2007 Jan; 16(1):57-62. PubMed ID: 17220332
[TBL] [Abstract][Full Text] [Related]
16. Insulin-like growth factor receptor (IGF-1R) in breast cancer subtypes.
Yerushalmi R; Gelmon KA; Leung S; Gao D; Cheang M; Pollak M; Turashvili G; Gilks BC; Kennecke H
Breast Cancer Res Treat; 2012 Feb; 132(1):131-42. PubMed ID: 21574055
[TBL] [Abstract][Full Text] [Related]
17. Relationship of circulating insulin-like growth factor-I and binding proteins 1-7 with mammographic density among women undergoing image-guided diagnostic breast biopsy.
Hada M; Oh H; Pfeiffer RM; Falk RT; Fan S; Mullooly M; Pollak M; Geller B; Vacek PM; Weaver D; Shepherd J; Wang J; Fan B; Mahmoudzadeh AP; Malkov S; Herschorn S; Brinton LA; Sherman ME; Gierach GL
Breast Cancer Res; 2019 Jul; 21(1):81. PubMed ID: 31337427
[TBL] [Abstract][Full Text] [Related]
18. Insulin-like growth factor receptor-1 (IGF-1R) expression in normal breast, proliferative breast lesions, and breast carcinoma.
Bhargava R; Beriwal S; McManus K; Dabbs DJ
Appl Immunohistochem Mol Morphol; 2011 May; 19(3):218-25. PubMed ID: 21217522
[TBL] [Abstract][Full Text] [Related]
19. Plasma insulin-like growth factor (IGF) I, IGF-binding protein 3, and mammographic density.
Byrne C; Colditz GA; Willett WC; Speizer FE; Pollak M; Hankinson SE
Cancer Res; 2000 Jul; 60(14):3744-8. PubMed ID: 10919644
[TBL] [Abstract][Full Text] [Related]
20. Expression of insulin-like growth factor 1 receptor (IGF-1R) predicts poor responses to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in non-small cell lung cancer patients harboring activating EGFR mutations.
Yeo CD; Park KH; Park CK; Lee SH; Kim SJ; Yoon HK; Lee YS; Lee EJ; Lee KY; Kim TJ
Lung Cancer; 2015 Mar; 87(3):311-7. PubMed ID: 25617986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
